Currently, several AI applications have been reported also in the field of LC pathology; these include the distinction between healthy parenchyma and tumor, the detection of lymph node metastases, the count of tumor cells, the determination of the immunohistochemical status of the tumor, the determination of predictive biomarkers including programmed death ligand 1 (PD‐L1) status and genetic mutations, risk stratification, and the prediction of response to treatments. Here, CD274 is linked to neoplasm.